Allogene Therapeutics, Inc.
8-K
May 28, 2026
Key Highlights
- Pioneering 'off-the-shelf' CAR-T cell therapy technology
- Planned CEO transition ensures strategic continuity
- Internal leadership appointment signals R&D stability
Read Analysis
🤖 AI Generated